Sumitomo Pharma Co., Ltd. (DNPUF)

Sumitomo Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	4,668	1,934	1,045	2,421	3,952	6,922
Market Cap Growth	136.02%	85.01%	-56.82%	-38.75%	-42.91%	33.63%
Enterprise Value	5,952	3,864	3,527	2,604	4,995	8,376
Last Close Price	12.67	4.76	2.40	6.38	10.22	18.75
PE Ratio	6.65	12.26	-	-	8.51	13.62
PS Ratio	1.61	0.73	0.50	0.58	0.86	1.48
PB Ratio	2.53	1.71	1.01	0.79	0.71	1.18
P/TBV Ratio	-	-	-	-	34.15	37.03
P/FCF Ratio	15.54	36.19	-	92.74	20.09	5.91
P/OCF Ratio	13.74	17.55	-	26.96	15.36	5.65
EV/Sales Ratio	2.06	1.45	1.70	0.62	1.08	1.80
EV/EBITDA Ratio	7.17	15.00	-	-	6.17	12.04
EV/EBIT Ratio	8.60	44.43	-	-	10.12	17.06
EV/FCF Ratio	19.82	72.31	-	99.75	25.39	7.15
Debt / Equity Ratio	0.90	1.85	2.74	0.85	0.42	0.45
Debt / EBITDA Ratio	1.99	8.14	-	-	2.89	3.78
Debt / FCF Ratio	5.50	39.27	-	99.82	11.91	2.24
Net Debt / Equity Ratio	0.70	1.72	2.55	0.50	0.12	0.15
Net Debt / EBITDA Ratio	1.55	7.55	-1.26	-2.38	0.83	1.26
Net Debt / FCF Ratio	4.28	36.38	-1.58	58.47	3.41	0.75
Asset Turnover	0.54	0.48	0.31	0.46	0.43	0.40
Inventory Turnover	1.95	1.46	1.21	1.85	1.64	1.61
Quick Ratio	0.91	0.43	0.25	0.65	1.27	1.19
Current Ratio	1.40	1.07	0.52	1.03	1.79	1.65
Return on Equity (ROE)	48.39%	14.52%	-111.89%	-17.90%	6.14%	5.75%
Return on Assets (ROA)	8.13%	0.99%	-21.74%	-6.46%	2.86%	2.65%
Return on Invested Capital (ROIC)	22.11%	2.56%	-60.99%	-18.52%	3.91%	3.23%
Return on Capital Employed (ROCE)	18.00%	2.60%	-90.60%	-16.50%	5.80%	5.30%
Earnings Yield	15.04%	8.16%	-199.19%	-23.15%	11.75%	7.34%
FCF Yield	6.43%	2.76%	-159.79%	1.08%	4.98%	16.92%
Dividend Yield	-	-	-	2.48%	2.26%	1.35%
Payout Ratio	0.00%	0.01%	-	-	19.72%	19.78%
Total Shareholder Return	-	-	-	2.48%	2.26%	1.35%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.